Cargando…
P1433: USE OF A FOAMY-VIRUS VECTOR SYSTEM TO PRODUCE AN ‘OFF-THE-SHELF’ ANTI-CD19 CAR T CELL PRODUCT
Autores principales: | Lazana, I., Simantirakis, E., Daniil, M., Tsironis, I., Vassilopoulos, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429678/ http://dx.doi.org/10.1097/01.HS9.0000848588.15468.00 |
Ejemplares similares
-
P1386: USE OF A FOAMY-VIRUS VECTOR SYSTEM TO PRODUCE AN ‘OFF-THE-SHELF’ FCΓ-CR-T CELL PRODUCT FOR THE TREATMENT OF HEMATOLOGICAL AND SOLID TUMOR MALIGNANCIES
por: Lazana, Ioanna, et al.
Publicado: (2023) -
FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs
por: Simantirakis, Emmanouil, et al.
Publicado: (2020) -
An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies
por: Xiang, Jingyu, et al.
Publicado: (2023) -
P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
por: Huang, Ruihao, et al.
Publicado: (2023) -
Efficient liver gene transfer with foamy virus vectors
por: Zacharoulis, Dimitris, et al.
Publicado: (2013)